Toshiba America Medical Systems has debuted four multifrequency transducers to expand its flagship PowerVision ultrasound scanner's pelvic, vascular, and transcranial capabilities. The Tustin, CA-based vendor also released SmartTrace, a spectral Doppler
Toshiba America Medical Systems has debuted four multifrequency transducers to expand its flagship PowerVision ultrasound scanner's pelvic, vascular, and transcranial capabilities. The Tustin, CA-based vendor also released SmartTrace, a spectral Doppler quantification mode for vascular and abdominal studies.
The newest additions to Toshiba's line of probes are two endocavity transducers, a linear-array transducer for peripheral vascular and small-parts exams, and a phased-array sector transducer for transcranial applications. For endocavity imaging, the vendor's PVK-651VT transducer offers an extended 150 field-of-view, which allows physicians to distinguish between intrauterine and ectopic pregnancies, as well as to detect fetal abnormalities, according to the company. The vendor's PVK-720ST transducer, on the other hand, helps physicians to anatomically and hemodynamically evaluate the prostate gland and pelvic cavity with a 120 field-of-view, according to Toshiba.
In vascular and small-parts applications, PLK-503AT supports routine screening and imaging for examining palpable and nonpalpable lesions, including adenomas, fluid collections, and cysts, according to the company. The PSK-20CT phased-array transducer is targeted for the evaluation of intracranial stenosis, occlusions, and several other transcranial applications.
With the company's SmartTrace technique, the Doppler waveform is automatically traced, eliminating the need for manual manipulation, according to the company. The technique, particularly suitable for vascular and abdominal studies, leads to ultrasound exams that are more quantitative, less subjective, and easier to perform, said Suzanne Certain, director of ultrasound marketing.
Four Strategies to Address the Tipping Point in Radiology
January 17th 2025In order to flip the script on the impact of the radiology workforce shortage, radiology groups and practices need to make sound investments in technologies and leverage partnerships to mitigate gaps in coverage and maximize workflow efficiencies.
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI-Based AI Enhance Risk Stratification in Prostate Cancer?
January 13th 2025Employing baseline MRI and clinical data, an emerging deep learning model was 32 percent more likely to predict the progression of low-risk prostate cancer (PCa) to clinically significant prostate cancer (csPCa), according to new research.